Generation Bio Co. Common Stock
(NASDAQ:GBIO)
Description
Generation Bio Co., a genetic medicines company, develops gene therapies for the treatment of rare and prevalent diseases. The company is developing a portfolio of programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
GBIO Overview
None
Sector |
Health Care |
Industry |
Major Pharmaceuticals |
Previous Close |
$5.3300 |
Previous Close Volume |
121590 |